Nexium capsules Helicobacter pylori Specific Clinical Experience Investigation

Study identifier:D961HC00011

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Nexium capsules Specific Clinical Experience Investigation concerning Helicobacter pylori eradication

Medical condition

Gastric Ulcer, lymphoma idiopathic thrombocytopenic purpura

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

369

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Sept 2011

Primary Completion Date: 01 Mar 2014

Study Completion Date: 01 Mar 2014

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2014 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
Nexium	-

Documents available

CSR__Synopsis_D961HC00011
Download
D961HC00011_Protocol
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Japan Central Study Information

[email protected]

Investigators

Principal Investigator

Shigeru Yoshida

Astrazeneca K.K.